Metraipolis › archive › dc_bd401cfce087
State-of-the-art and future developments in dosimetry for SSTR- and PSMA-targeting radioligand therapies — Europe PMC PMID:41864828
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41864828
- DOI
- 10.1016/j.zemedi.2026.03.011
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T03:36:02.181Z
- SHA-256 of the archived text
d87bb0ccc0bb21fbb4192d58089fc4e634c843124b55036286cd1f4f73d333a6- Stable URL of this page
https://metraipolis.com/documento/dc_bd401cfce087
How to cite
State-of-the-art and future developments in dosimetry for SSTR- and PSMA-targeting radioligand therapies — Europe PMC PMID:41864828 — Europe PMC (en), https://europepmc.org/article/MED/41864828 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd401cfce087 (Metraipolis archive dc_bd401cfce087, sha256 d87bb0ccc0bb21fbb4192d58089fc4e634c843124b55036286cd1f4f73d333a6)
BibTeX
@misc{dcbd401cfce087,
title = {State-of-the-art and future developments in dosimetry for SSTR- and PSMA-targeting radioligand therapies — Europe PMC PMID:41864828},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41864828},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd401cfce087; sha256 d87bb0ccc0bb21fbb4192d58089fc4e634c843124b55036286cd1f4f73d333a6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41864828. Agents can read the archived copy with the MCP tool read_document.